As on 01-Dec-2023 IST
₹1,225.85
₹1,233.05
₹1,241.85
₹1,225.00
17,49,751
₹922.45 - 1,241.85
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
---|---|---|---|---|---|---|---|
Sun Pharmaceutical
| 22.95 | 13.10 | 10.76 | 17.70 | 34.01 | 20.11 | 7.97 |
S&P BSE Sensex
| 10.91 | 5.65 | 4.09 | 6.94 | 15.19 | 13.27 | 12.49 |
S&P BSE Healthcare
| 32.32 | 11.76 | 9.26 | 27.28 | 14.47 | 16.29 | 12.36 |
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
2016
|
|
---|---|---|---|---|---|---|---|
Sun Pharmaceutical
| 18.41 | 41.84 | 36.39 | -0.23 | -25.01 | -9.34 | -22.75 |
S&P BSE Sensex
| 4.44 | 21.99 | 15.75 | 14.38 | 5.87 | 27.91 | 1.95 |
S&P BSE Healthcare
| -12.10 | 20.87 | 61.45 | -3.55 | -5.89 | 0.49 | -12.88 |
Stock
|
Peer Median
|
||
---|---|---|---|
Please wait... |
Stock
|
Peer Median
|
||
---|---|---|---|
Please wait... |
The total asset value of Sun Pharmaceutical Industries Ltd. stood at ₹ 79,441 Cr as on 30-Sep-23
The share price of Sun Pharmaceutical Industries Ltd. is ₹1,231.25 (NSE) and ₹1,231.25 (BSE) as of 01-Dec-2023 IST. Sun Pharmaceutical Industries Ltd. has given a return of 34.01% in the last 3 years.
Sun Pharmaceutical Industries Ltd. has a market capitalisation of ₹ 2,95,418 Cr as on 01-Dec-2023. As per Value Research classification, it is a Large Cap company.
The P/B ratio of Sun Pharmaceutical Industries Ltd. is 4.94 times as on 01-Dec-2023, a 0.51% premium to its peers’ median range of 3.28 times.
The P/E ratio of Sun Pharmaceutical Industries Ltd. is 34.56 times as on 01-Dec-2023, a 0.15% premium to its peers’ median range of 30.01 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Sun Pharmaceutical Industries Ltd. and enter the required number of quantities and click on buy to purchase the shares of Sun Pharmaceutical Industries Ltd..
Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers formulations in various therapeutic areas, including central nervous system, dermatology, cardiology, oncology, neuropsychiatry, gastroenterology, anti-infectives, diabetology, pain/analgesics, vitamins/minerals/nutrients, respiratory, gynaecology, urology, ophthalmology, orthopaedic, nephrology, dental, and other areas. It provides APIs for anti-cancers, peptides, steroids, hormones, and immunosuppressant drugs. In addition, the company offers generic medications, such as tablets, capsules, injectables, inhalers, ointments, creams, and liquids; speciality medications, and anti retro viral medications, as well as over-the-counter products. The company was founded in 1983 and is based in Mumbai, India.
The promoters of Sun Pharmaceutical Industries Ltd. are Shanghvi Finance Private Limited and Dilip Shantilal Shanghvi. They collectively own 49.9 per cent of the total equity. The chairman of the company is
The promoters of Sun Pharmaceutical Industries Ltd. have pledged 1.33% of the total equity as on Sep-23.
Some of the close peers are:
Company | Market Cap(₹ Cr) |
---|---|
1,00,675
|
|
97,419
|
|
95,867
|
|
72,810
|
Sun Pharmaceutical Industries Ltd. | Ratios |
---|---|
Return on equity(%)
|
15.48
|
Return on capital employed(%)
|
--
|
Debt-to-equity ratio
|
0
|
Dividend yield(%)
|
0.93
|
Yes, TTM profit after tax of Sun Pharmaceutical Industries Ltd. was ₹8,549 Cr.
Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers formulations... in various therapeutic areas, including central nervous system, dermatology, cardiology, oncology, neuropsychiatry, gastroenterology, anti-infectives, diabetology, pain/analgesics, vitamins/minerals/nutrients, respiratory, gynaecology, urology, ophthalmology, orthopaedic, nephrology, dental, and other areas. It provides APIs for anti-cancers, peptides, steroids, hormones, and immunosuppressant drugs. In addition, the company offers generic medications, such as tablets, capsules, injectables, inhalers, ointments, creams, and liquids; speciality medications, and anti retro viral medications, as well as over-the-counter products. The company was founded in 1983 and is based in Mumbai, India. Read more
Sign up and get access to:
Unlimited access to advice from India's top experts
The most comprehensive analysis of funds and stocks in India
A holistic portfolio manager to help track all your investments easily
And much more, like guides, tools, webinars, videos and eBooks.